• Excellent precision
  • Very low detection limit
  • Best functional assay sensitivity (FAS)


Clinical indication

The B·R·A·H·M·S PlGF plus KRYPTOR assay is indicated to be used in conjunction with additional clinical data as an aid in assessing the risk of fetal trisomy 21 and the risk for developing pre-eclampsia in first trimester screening of pregnant women.
The B·R·A·H·M·S PlGF plus KRYPTOR assay is intended to be used - together with the B·R·A·H·M·S sFlt-1 KRYPTOR assay and additional clinical and diagnostic findings - as an aid in the diagnosis of pre-eclampsia and/or short-term prognosis of pre-eclampsia in pregnant women with suspicion of pre-eclampsia.


Ease of handling

Sample volume 70 µL
Sample type Serum, EDTA plasma
Incubation time 29 min
Measuring range 3.6 to 7 000 pg/mL
Detection limit 3.6 pg/mL
Functional assay sensitivity (FAS) 6.7 pg/mL
Kit stability on board 29 days
Calibrator 1 point
Calibration stability 15 days


Hight sensitivity and wide measuring range

With a the lowest FAS and lowest cross-reactivity to other PlGF isoforms B·R·A·H·M·S PlGF plus KRYPTOR provides the high sensitivity needed for reliably measuring PlGF levels in first trimester. The wide measuring range also allows to reliably measure high clinical values in second and third trimester.



B·R·A·H·M·S PlGF plus KRYPTOR is available on:


Kit and accessories

Article number Description


Kit, reagents for 75 determinations



Calibrator kit, 6 vials



Control kit, 3 levels (2 vials per level)


Contact us >


Further links on prenatal screening products and assays

thermo scientific applied biosystems invitrogen fisher scientific unity lab service